21 May 2013
Keywords: biogen, idec/vernalis, initiate, ph, ii, trials, novel
Article | 14 May 2007
US drugmaker Biogen Idec has initiated a Phase II program of BIIB014 (also known as V2006), an oral compound co-developed ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
14 May 2007
20 May 2013
© 2013 thepharmaletter.com